About Indio Labs
Indio Labs is a company based in Bengaluru (India) founded in 2013 by Siraj Bagwan. Indio Labs has raised $5.14 million across 4 funding rounds from investors including Department of Biotechnology, Vmms Holdings and Abdul Rahman Ali Al Khudair Holding. Indio Labs operates in a competitive market with competitors including Epic Sciences, BioImagene, Predicine, Elypta and AcuamarkDx, among others.
- Headquarter Bengaluru, India
- Founders Siraj Bagwan
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Indio Labs Private Limited
- Date of Incorporation 30 Jul, 2013
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$34.56 (USD)8.21as on Mar 31, 2021
-
Net Profit
-$2.46 K (USD)61.82as on Mar 31, 2021
-
EBITDA
-$1.02 K (USD)62.84as on Mar 31, 2021
-
Total Equity Funding
$5.14 M (USD)
in 4 rounds
-
Latest Funding Round
$251.71 K (USD), Series A
May 22, 2016
-
Investors
Department of Biotechnology
& 41 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Indio Labs
Indio Labs has successfully raised a total of $5.14M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $251.71 thousand completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Indio Labs
Indio Labs has secured backing from 42 investors, including institutional and angel investors. Prominent investors backing the company include Department of Biotechnology, Vmms Holdings and Abdul Rahman Ali Al Khudair Holding.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Biotechnology research, guidelines, and funding by the Government of India.
|
Locked | Locked | Locked |
Investor details for Indio Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Indio Labs
Investment portfolio details for Indio Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Indio Labs
Detailed financials for Indio Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Indio Labs Comparisons
Peer comparison for Indio Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Indio Labs
Indio Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Epic Sciences, BioImagene, Predicine, Elypta and AcuamarkDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive tests for detecting circulating tumor cells are provided.
|
|
| Locked | Locked | Locked |
Digital pathology tools are developed for diagnostics and drug discovery.
|
|
| Locked | Locked | Locked |
Developer of liquid biopsy assays and biomarker discovery for cancer
|
|
| Locked | Locked | Locked |
Liquid biopsy-based molecular diagnostics for cancer detection are provided.
|
|
| Locked | Locked | Locked |
Non-invasive screening tests for early cancer detection are provided.
|
|
| Locked | Locked | Locked |
Exosome-based drugs and diagnostics for cancer treatment are developed.
|
Detailed competitors of Indio Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Indio Labs
Complete news archive for Indio Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indio Labs
Indio Labs was founded in 2013.
Indio Labs is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Indio Labs is a funded company, having raised a total of $5.14M across 4 funding rounds to date.
Annual revenue of Indio Labs is $34.56 as on Mar 31, 2021.
Developers of cost-effective biomedical devices. Their BioScoop biopsy system is a device for soft tissue core biopsy. It enables physicians achieve definitive tissue capture using a novel needle design, advanced needle-tissue characterization and automated control. Its other product, BxSeal is a safety feature offered to the biopsy device to assist in concurrently delivering a haemostatic agent inside the biopsy track to reduce the risk of internal haemorrhage.
Indio Labs's top competitors include Pacific Edge, AcuamarkDx and Elypta.
Indio Labs has 42 investors. Key investors include Department of Biotechnology, Vmms Holdings, Abdul Rahman Ali Al Khudair Holding, Noda Subrya Bhat, and Pradeep Rajan.
The valuation of Indio Labs is $3.06M as of May 2016.